Abstract
Introduction and hypothesis
The purpose of this study is to describe risk factors for post-operative urinary tract infection (UTI) the first year after stress urinary incontinence surgery.
Methods
Multivariable logistic regression analyses were performed on data from 1,252 women randomized in two surgical trials, Stress Incontinence Surgical Treatment Efficacy trial (SISTEr) and Trial Of Mid-Urethral Slings (TOMUS).
Results
Baseline recurrent UTI (rUTI; ≥3 in 12 months) increased the risk of UTI in the first 6 weeks in both study populations, as did sling procedure and self-catheterization in SISTEr, and bladder perforation in TOMUS. Baseline rUTI, UTI in the first 6 weeks, and PVR > 100 cc at 12 months were independent risk factors for UTI between 6 weeks and 12 months in the SISTEr population. Few (2.3–2.4%) had post-operative rUTI, precluding multivariable analysis. In women with pre-operative rUTI, successful surgery (negative cough stress test) at 1 year did not appear to decrease the risk of persistent rUTI.
Conclusions
Pre-operative rUTI is the strongest risk factor for post-operative UTI.
Similar content being viewed by others
References
Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1A):5S–13S
Albo ME, Richter HE, Brubaker L, Norton P, Kraus S, Zimmern PE et al (2007) Burch coloposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356:2143–2155
Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriquez LV (2007) Complication of sling surgery among female Medicare beneficiaries. Obstet Gynecol 109:707–714
Kunin CM (1994) Urinary tract infections in females. Clin Infect Dis 18:1–10
Melville JL, Katon W, Delaney K, Newton K (2005) Urinary incontinence in US women: a population-based study. Arch Intern Med 165:537–542
Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. NEJM 335:468–474
Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF (1999) Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 94:66–70
Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B et al (2001) Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 98:1045–1052
Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R et al (2001) Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol 54:710–718
Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J et al (2004) Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164:989–993
Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, Stamm WE (2000 Jan) Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 30(1):152–156
Moore EE, Jackson SL, Boyko EJ, Scholes D, Fihn SD (2008 Feb) Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol 111(2 Pt 1):317–323
Richter HE, Albo ME, Zyczynski HM et al (2010 Jun 3) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362(22):2066–2076
FitzGerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, Zyczynski HM, Fine P, Weber AM (2008) Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J 19:1603–1609
Sutkin G, Lowder JL, Smith KJ (2009) Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis. Int Urogynecol J 20:933–938
Stern JA, Hsieh Y, Schaeffer AJ (2004) Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 171:768–770
Hampson SJ, Noble JG, Rickards D, Milroy EJ (1992) Does residual urine predispose to urinary tract infection? Br J Urol 70:506
Phipps S, Lim YN, McClinton S, Barry C, Rane A, N'Dow J (2006) Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev 19(2):CD004374
Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW (2010) Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials Pharmacoepidemiol Drug Saf 19:1287–1292
Acknowledgments
This study was supported by NIH grants U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60401, U01 DK60397, U01 DK 58225, U01 DK60395, U01 DK58234, U01 DK60393, U01 DK58229.
Conflicts of interest
The authors report no financial disclosures with the following exceptions: Linda Brubaker received grant support and honorarium from Pfizer; Toby Chai received grant support from Allergan and honorarium from Pfizer; Anne Stoddard has stocks in Bristol-Meyers Squibb, Johnson and Johnson, Elan Corp., Proctor and Gamble, and Stryker.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
For SISTEr
Steering committee
William Steers, M.D., Chair (University of Virginia Charlottesville, VA); Ananias Diokno, M.D., Veronica Mallett, M.D. (William Beaumont Hospital, Royal Oak, MI, and Oakwood Hospital, Dearborn, MI; U01 DK58231); Linda Brubaker, M.D., and MaryPat FitzGerald, M.D. (Loyola University Medical Center, Maywood, IL; U01 DK60379); Holly E. Richter, Ph.D., M.D., L. Keith Lloyd, M.D. (University of Alabama, Birmingham, AL; U01 DK60380); Michael Albo, M.D., Charles Nager, M.D. (University of California, San Diego, CA; U01 DK60401); Toby C. Chai, M.D.; Harry W. Johnson, M.D. (University of Maryland, Baltimore, M.D.; U01 DK60397); Halina M. Zyczynski, M.D.; Wendy Leng, M.D. (University of Pittsburgh, Pittsburgh, PA; U01 DK 58225); Philippe Zimmern, M.D.; Gary Lemack, M.D. (University of Texas Southwestern, Dallas, TX; U01 DK60395); Stephen Kraus, M.D.; Thomas Rozanski, M.D. (University of Texas Health Sciences Center, San Antonio, TX; U01 DK58234); Peggy Norton, M.D.; David Lesser, M.D. (University of Utah, Salt Lake City, UT; U01 DK60393); Sharon Tennstedt, Ph.D.; Anne Stoddard, ScD (New England Research Institutes, Watertown, MA; U01 DK58229); Debuene Chang, M.D.; John W. Kusek, Ph.D.; Leroy M. Nyberg, M.D., Ph.D. (National Institute of Diabetes & Digestive & Kidney Diseases); Anne M. Weber, M.D. (National Institute of Child Health and Human Development).
Co-investigators
Rowell S. Ashford II, M.D.; Jan Baker, APRN; Diane Borello-France, PT, Ph.D.; Kathryn L. Burgio, Ph.D.; Seine Chiang, M.D.; Ash Dabbous, M.D.; Patricia S. Goode, M.D.; Lee N. Hammontree, M.D.; Kimberly Kenton, M.D.; Salil Khandwala, M.D.; Karl Luber, M.D.; Emily Lukacz, M.D.; Shawn Menefee, M.D.; Pamela Moalli, M.D.; Kenneth Peters, M.D.; Elizabeth Sagan, M.D.; Joseph Schaffer, M.D.; Amanda Simsiman, M.D.; Larry Sirls, M.D.; Robert Starr, M.D.; R. Edward Varner, M.D..
Study coordinators
Rosemary Bradt, RNC; Karen Debes, RN; Rosanna Dinh, RN, CCRC; Judy Gruss, RN; Lynn Hall, RN, MSN, CURN; Alice Howell, RN, BSN, CCRC; Kathy Jesse, RN; D. Lynn Kalinoski, Ph.D.; Kathryn Koches, RN; Barbara Leemon, RN; Karen Mislanovich, RN; Shelly O'Meara, RN; Janese Parent, RN; Norma Pope, RN; Caren Prather, RN; Terry Rogers, RN; Sylvia Sluder, CCRP; Mary Tulke, RN.
Biostatistical coordinating center
Kimberly J. Dandreo, MSc; Corinne J. Leifer, BA; Susan M. McDermott, MPH, GNP; Anne Stoddard, ScD (Co-PI); Sharon Tennstedt, Ph.D. (PI); Liane Tinsley, MPH; Lisa Wruck, ScD; Yan Xu, MS.
Data safety and monitoring board
Elizabeth A. Gormley, M.D. (Chair), Dartmouth-Hitchcock Medical Center, Lebanon NH; Paul Abrams, M.D., Bristol Urological Institute, Bristol, UK; Diedre Bland, M.D., Blue Ridge Medical Associates, Winston Salem NC; J. Quentin Clemens, M.D., Northwestern University Medical School, Chicago, IL; John Connett, Ph.D., University of Minnesota, Minneapolis, MN; William Henderson, Ph.D., University of Colorado, Aurora, CO; Dee Fenner, M.D., University of Michigan; Ann Arbor, MI; Sheryl Kelsey, Ph.D., University of Pittsburgh, Pittsburgh, PA; Deborah Myers, M.D., Brown University School of Medicine, Providence, RI; Jacek Mostwin, M.D., Johns Hopkins Hospital, Baltimore, MD; Bassem Wadie, MBBCh, MSc, M.D., Mansoura Urology and Nephrology Center, Mansoura, Egypt.
For TOMUS
Steering committee
Elizabeth A. Gormley, Chair (Dartmouth-Hitchcock Medical Center, Lebanon, NH); Larry Sirls, M.D.; Salil Khandwala, M.D. (William Beaumont Hospital, Royal Oak, MI, and Oakwood Hospital, Dearborn, MI; U01 DK58231); Linda Brubaker, M.D.; Kimberly Kenton, M.D. (Loyola University Chicago, Stritch School of Medicine, Maywood, IL; U01 DK60379); Holly E. Richter, Ph.D., M.D.; L. Keith Lloyd, M.D. (University of Alabama, Birmingham, AL; U01 DK60380); Michael Albo, M.D.; Charles Nager, M.D. (University of California, San Diego, CA; U01 DK60401); Toby C. Chai, M.D.; Harry W. Johnson, M.D. (University of Maryland, Baltimore, MD; U01 DK60397); Halina M. Zyczynski, M.D.; Wendy Leng, M.D. (University of Pittsburgh, Pittsburgh, PA; U01 DK 58225); Philippe Zimmern, M.D.; Gary Lemack, M.D. (University of Texas Southwestern, Dallas, TX; U01 DK60395); Stephen Kraus, M.D.; Thomas Rozanski, M.D. (University of Texas Health Sciences Center, San Antonio, TX; U01 DK58234); Peggy Norton, M.D.; Ingrid Nygaard, M.D. (University of Utah, Salt Lake City, UT; U01 DK60393); Sharon Tennstedt, Ph.D.; Anne Stoddard, ScD (New England Research Institutes, Watertown, MA; U01 DK58229); Debuene Chang, M.D. (until 10/2009), John Kusek, Ph.D. (starting 10/2009), Rebekah Rasooly, Ph.D. (National Institute of Diabetes & Digestive & Kidney Diseases).
Co-investigators
Amy Arisco, M.D.; Jan Baker, APRN; Diane Borello-France, PT, Ph.D.; Kathryn L. Burgio, Ph.D.; Ananias Diokno, M.D.; MaryPat Fitzgerald, M.D.; Chiara Ghetti, M.D.; Patricia S. Goode, M.D.; Robert L. Holley, M.D.; Yvonne Hsu, M.D.; Margie Kahn, M.D.; Jerry Lowder, M.D.; Karl Luber, M.D.; Emily Lukacz, M.D.; Alayne Markland, DO, MSc; Shawn Menefee, M.D.; Pamela Moalli, M.D.; Elizabeth Mueller, M.D.; Leslie Rickey, M.D., MPH; Elizabeth Sagan, M.D.; Joseph Schaffer, M.D.; Robert Starr, M.D.; Gary Sutkin, M.D.; R. Edward Varner, M.D.; Emily Whitcomb, M.D..
Study coordinators
Laura Burr, RN; JoAnn Columbo, BS, CCRC; Tamara Dickinson, RN, CURN, CCCN, BCIA-PMDB; Rosanna Dinh, RN, CCRC; Judy Gruss, RN; Alice Howell, RN, BSN, CCRC; Chaandini Jayachandran, MSc; Kathy Jesse, RN; D. Lynn Kalinoski, Ph.D.; Barbara Leemon, RN; Karen Mislanovich, RN; Elva Kelly Moore, RN; Caren Prather, RN; Jennifer Tabaldo; Tia Thrasher; Mary Tulke, RN; Robin Willingham, RN, BSN; Kimberly Woodson, RN, MPH; Gisselle Zazueta-Damian.
Data coordinating center
Kathleen Cannon, BS; Kimberly J. Dandreo, MSc; Liyuan Huang, MS; Rose Kowalski, MA; Heather Litman, Ph.D.; Marina Mihova, MHA; Anne Stoddard, ScD (Co-PI); Kerry Tanwar, BA; Sharon Tennstedt, Ph.D. (PI); Yan Xu, MS.
Data safety and monitoring board
J. Quentin Clemens, M.D. (Chair) Northwestern University Medical School, Chicago IL; Paul Abrams, M.D., Bristol Urological Institute, Bristol, UK; Deidre Bland, M.D., Blue Ridge Medical Associates, Winston Salem, NC; Timothy B. Boone, M.D., The Methodist Hospital, Baylor College of Medicine, Houston, TX; John Connett, Ph.D., University of Minnesota, Minneapolis, MN; Dee Fenner M.D., University of Michigan, Ann Arbor, MI; William Henderson, Ph.D., University of Colorado, Aurora, CO; Sheryl Kelsey, Ph.D., University of Pittsburgh, Pittsburgh, PA; Deborah J. Lightner, M.D., Mayo Clinic, Rochester, MN; Deborah Myers, M.D., Brown University School of Medicine, Providence, RI; Bassem Wadie, MBBCh, MSc, M.D., Mansoura Urology and Nephrology Center, Mansoura, Egypt; J. Christian Winters, M.D., Louisiana State University Health Sciences Center, New Orleans, LA
Rights and permissions
About this article
Cite this article
Nygaard, I., Brubaker, L., Chai, T.C. et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J 22, 1255–1265 (2011). https://doi.org/10.1007/s00192-011-1429-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-011-1429-9